CbsBioscience Overview

  • Founded
  • 2003
  • Status
  • Private
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 1

CbsBioscience General Information


Operator of a big data and artificial intelligence-based precision medical company intended to provide customized medical services tailored to the characteristics of patients. The company provides prognosis prediction, anticancer drug companion, diagnosis technology development, and biomarker development, enabling patients to have access to various treatments through 3D integrated analysis.

Contact Information

Formerly Known As
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Other Healthcare Technology Systems
Primary Office
  • 24, Techno 11-ro
  • Daejeon, Yuseong-gu
  • South Korea
+82 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CbsBioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC 01-Jan-2011 Completed Clinical Trials - Phase 2
To view CbsBioscience’s complete valuation and funding history, request access »

CbsBioscience Executive Team (2)

Name Title Board Seat Contact Info
Jin-Young Park Founder and Chief Executive Officer
You’re viewing 1 of 2 executive team members. Get the full list »

CbsBioscience Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Korea Investment Partners Venture Capital Minority 000 0000 000000 0
To view CbsBioscience’s complete investors history, request access »